Literature DB >> 25673808

Unilateral ureteral obstruction attenuates intrarenal angiotensin II generation induced by podocyte injury.

Masahiro Okabe1, Yoichi Miyazaki2, Fumio Niimura3, Ira Pastan4, Akira Nishiyama5, Takashi Yokoo2, Iekuni Ichikawa6, Taiji Matsusaka7.   

Abstract

The renal tissue renin-angiotensin system is activated in chronic kidney diseases. We previously demonstrated that intrarenal ANG II is synthesized primarily from liver-derived angiotensinogen filtered through the glomerulus and that podocyte injury increases the passage of angiotensinogen into the tubular lumen and generation of ANG II. In the present study, we tested the effect of cessation of glomerular filtration by ureteral obstruction on renal ANG II generation in kidneys with podocyte injury under two experimental conditions. Ureteral obstruction is known to activate the renin-angiotensin system in nonproteinuric kidneys. Transgenic mice expressing hCD25 in podocyte (NEP25) were injected with 1.25 or 10 ng/g body wt of LMB2, a hCD25-targeted immunotoxin, subjected to unilateral ureteral ligation on the following day, and euthanized 7 and 4 days later, respectively. In both experiments, compared with the kidney in untreated wild-type mice, renal angiotensinogen protein, as assessed by immunostaining and Western blot analysis, was increased in the contralateral unobstructed kidney. However, it was markedly decreased in the obstructed kidney. Whereas intrarenal ANG II content was increased in the contralateral kidney compared with the untreated kidney (248 ± 83 vs. 106 ± 21 and 298 ± 185 vs. 64.8 ± 20 fmol/g kidney, respectively), this increase was suppressed in the obstructed kidney (161 ± 75 and 113 ± 34 fmol/g kidney, respectively), a pattern opposite to what we expected in obstructed kidneys without podocyte injury. Thus, our study indicates that the major source of increased renal ANG II in podocyte injury is filtered angiotensinogen.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  glomerulosclerosis; intrarenal angiotensin II; renin-angiotensin system; unilateral ureteral obstruction

Mesh:

Substances:

Year:  2015        PMID: 25673808      PMCID: PMC4398838          DOI: 10.1152/ajprenal.00444.2014

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  30 in total

Review 1.  Obstructive nephropathy and renal fibrosis.

Authors:  Saulo Klahr; Jeremiah Morrissey
Journal:  Am J Physiol Renal Physiol       Date:  2002-11

2.  Intrarenal renin angiotensin system revisited: role of megalin-dependent endocytosis along the proximal nephron.

Authors:  Marcus Pohl; Henriette Kaminski; Hayo Castrop; Michael Bader; Nina Himmerkus; Markus Bleich; Sebastian Bachmann; Franziska Theilig
Journal:  J Biol Chem       Date:  2010-10-21       Impact factor: 5.157

3.  Intrarenal Angiotensin ii is associated with inflammation, renal damage and dysfunction in dahl salt-sensitive hypertension.

Authors:  L Lin; W E Phillips; R D Manning
Journal:  J Am Soc Hypertens       Date:  2009 Sep-Oct

4.  Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats.

Authors:  Yukiko Nagai; Li Yao; Hiroyuki Kobori; Kayoko Miyata; Yuri Ozawa; Akira Miyatake; Tokihito Yukimura; Takatomi Shokoji; Shoji Kimura; Hideyasu Kiyomoto; Masakazu Kohno; Youichi Abe; Akira Nishiyama
Journal:  J Am Soc Nephrol       Date:  2005-01-12       Impact factor: 10.121

5.  Podocyte injury enhances filtration of liver-derived angiotensinogen and renal angiotensin II generation.

Authors:  Taiji Matsusaka; Fumio Niimura; Ira Pastan; Ayumi Shintani; Akira Nishiyama; Iekuni Ichikawa
Journal:  Kidney Int       Date:  2013-11-27       Impact factor: 10.612

Review 6.  Obstructive nephropathy: insights from genetically engineered animals.

Authors:  Jean-Loup Bascands; Joost P Schanstra
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

7.  Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria.

Authors:  Akira Nishiyama; Toshitaka Nakagawa; Hiroyuki Kobori; Yukiko Nagai; Noriyuki Okada; Yoshio Konishi; Takashi Morikawa; Michiaki Okumura; Isseiki Meda; Hideyasu Kiyomoto; Naohisa Hosomi; Takefumi Mori; Sadayoshi Ito; Masahito Imanishi
Journal:  J Hypertens       Date:  2008-09       Impact factor: 4.844

Review 8.  Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy.

Authors:  Robert L Chevalier; Michael S Forbes; Barbara A Thornhill
Journal:  Kidney Int       Date:  2009-04-01       Impact factor: 10.612

9.  Sequential changes in renal expression of renin-angiotensin system genes in acute unilateral ureteral obstruction.

Authors:  J L Pimentel; A Montero; S Wang; I Yosipiv; S el-Dahr; M Martínez-Maldonado
Journal:  Kidney Int       Date:  1995-10       Impact factor: 10.612

Review 10.  Angiotensin II blockade and renal protection.

Authors:  Hiroyuki Kobori; Hirohito Mori; Tsutomu Masaki; Akira Nishiyama
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more
  2 in total

Review 1.  Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting.

Authors:  Hui Lin; Frank Geurts; Luise Hassler; Daniel Batlle; Katrina M Mirabito Colafella; Kate M Denton; Jia L Zhuo; Xiao C Li; Nirupama Ramkumar; Masahiro Koizumi; Taiji Matsusaka; Akira Nishiyama; Martin J Hoogduijn; Ewout J Hoorn; A H Jan Danser
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

2.  Inhibition of IL-1β by Aliskiren Improved Renal AQP2 Expression and Urinary Concentration Defect in Ureteral Obstruction and Release.

Authors:  Shan Hu; Haixia Xie; Renfei Luo; Pinning Feng; Qiaojuan Liu; Mengke Han; Yonglun Kong; Xuenong Zou; Weidong Wang; Chunling Li
Journal:  Front Physiol       Date:  2019-09-13       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.